Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-29T07:09:28.436Z Has data issue: false hasContentIssue false

[No title]

Published online by Cambridge University Press:  02 January 2018

Alice Seabourne
Affiliation:
South Manchester University NHS Trust, Withington Hospital, West Didsbury, Manchester M20 2LR
Christopher S. Thomas
Affiliation:
South Manchester University NHS Trust, Withington Hospital, West Didsbury, Manchester M20 2LR
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1995

References

Drummond, L. M. & Davies, M. F. (1993) Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia. British Journal of Psychiatry, 162, 3842.Google Scholar
King, D. J. & Mills, P. J. (1993) Clozapine: the Hollywell experience with the first 24 patients. Irish Journal of Psychological Medicine, 2, 205207.Google Scholar
Meltzer, H. Y. (1992) Some personal recommendations about using Clozaril. Clozaril Newsletter, 4, 13.Google Scholar
Revicki, D. A., Luce, B. R., Weschler, J. M., Brown, R. E. & Adler, M. A. (1990) Cost-effectiveness of clozapine for treatment-resistant schizophrenia patients. Hospital and Community Psychiatry, 41, 850854.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.